Well. Any one watching MRNA lately? Was that a 20% gain in one day? Too bad I didn't have a thousand shares. Oh Well. nice gain anyway.
They are having a little tiff with the NIH over patent rights to their particular mRNA sequence that codes for the Covid Spike protein, but I think it will be resolved amicably. This is tremendously promising science, and not just for vaccine development. They are already working on an update to include Omicron. Say it will be ready early 2022. Their big problem right now is meeting demand, and that's a wonderful problem to have for a young company.